Gene, Cell, And RNA Therapy Landscape

This series provides comprehensive details on the magnitude of development—3,366 gene and cell therapies in development globally from the preclinical through pre-registration stages—and changes in the breakdown offactors like modality and therapeutic area.
Highlights in Q3 2021 include the approvals of two new gene therapies in the European Union (EU) and China, the expansion of two gene therapy approvals to new regions (South Korea and the EU), continued growth ingene therapy research, and growth in the RNA therapeutic space ofstudies of anti-infective prophylactic vaccines.